Medscape14d
Immunogenicity and Safety of Inactivated Quadrivalent and Trivalent Influenza Vaccines in Children 18–47 Months of Age
A total of 599 children were enrolled in the study, of which all received at least 1 vaccination, and 584 completed the study (Trial Profile, Supplemental Digital Content 1, https://links.lww.com ...
Pharmaceutical Technology22d
Fluzone QIV HD by Sanofi for Unspecified Influenza Virus Infections: Likelihood of Approval
Influenza [strains A/H1N1 + A/H3N2 + B/Victoria + B/Yamagata] (quadrivalent, inactivated, split virion) Vaccine (Fluzone / Efluelda) is an egg-based vaccine, propagated in embryonated chicken eggs. It ...
Medscape28d
Enhanced T-Cell Immunogenicity of Plasmid DNA Vaccines Boosted by Recombinant Modified Vaccinia Virus Ankara in Humans
In animals, effective immune responses against malignancies and against several infectious pathogens, including malaria, are mediated by T cells. Here we show that a heterologous prime-boost ...
Pharmaceutical Technology28d
Influenza [types A and B] (quadrivalent) vaccine by CSL for Unspecified Influenza Virus Infections: Likelihood of Approval
Influenza [types A and B] (quadrivalent) vaccine is under clinical development by CSL and currently in Phase III for Unspecified Influenza Virus Infections. According to GlobalData, Phase III drugs ...